Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.
Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.
Amongst its offerings was the IOLMaster 500 which it claims is the fastest way of calculating the right IOL for every patient. It is part of the ZEISS Toric Solution and, via the FORUM platform, is an integral component of the ZEISS Ophthalmic Data Management Solution, a platform for the management of patient, diagnostic and OR data, for a paperless workflow in the doctor's practice and operating room.
The bitoric MICS intraocular lenses are a new standard range (lenses to +4.0 D cyl and 16-24 D sph) The lenses can be calculated quickly and simply using the Z CALC online calculator.
The AT LISA toric 909MV belongs to the ZEISS IOL family featuring violet filters. Besides UV protection these IOLS offer protection from the potentially more dangerous violet light spectrum. At the same time they transmit blue light, which plays an important role in regulation of the circadian rhythm, without impairing visual quality.
In the OVD Portfolio are the visco-elastic substances used for cataract treatment to enhance visibility of the operation area during the procedure and protect the corneal endothelium.
OPMI Lumera 700 is a surgical microscope which combines basic configuration with extensive options for surgery in the anterior and posterior ocular segments. The new RESIGHT 700 fundus viewing system and innovative Stereo Coaxial Illumination (SCI) illumination technology, allows the doctor to see the patient's eye with detail and brilliance.
Dr Ludwin Monz, President and CEO of Carl Zeiss Meditec AG said: We have developed these innovations in close dialogue with our customers and we remain on course to further success as a solution provider for ophthalmology and therefore make a contribution to the more effective and efficient treatment of diseases.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.